Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSPharmaceutical companies have a problem: There are a plethora of free insights at their fingertips from widely available sources – like scientific papers, clinical trial databases, regulatory reviews and drug labels, or internal legacy reports – that can help them improve drug safety, but this valuable information is often buried in these documents as unstructured text.
Understanding the safety landscape around any drug, adverse event (AE), or drug target is a critical part of drug development, from initial therapeutic target selection to post-market surveillance. Effective access to the right information brings value in safety assessment and risk management.
However, to uncover this information, pharmaceutical companies need tools that will help them unlock data that was previously inaccessible to obtain new insights, break down silos, and boost innovation. For example, manual search and review of safety literature is slow and repetitive, abstracts can take one-to-two minutes to review, and full articles around 15-to-20 minutes. To solve these problems, many pharma companies have turned to natural language processing (NLP), an artificial intelligence-based technology that automates data mining.
Leveraging NLP, IQVIA Safety Intelligence Hub integrates the right content, including literature, drug labels, FDA and EMA regulatory approval packages, with ontologies, intuitive queries, and easy-to-use searches, to rapidly deliver the information that safety teams need. This provides a dedicated hub of information that enables safety assessment teams, medical reviewers, drug safety experts, and toxicologists to contextualize and understand safety signals.
The hub helps safety teams to reduce time spent on accessing the right information from key safety data sources, to answer important questions such as:
NLP enriches relevant data sources with life science ontologies around drugs and AEs, including MedDRA, making them easy to search effectively. FDA reviews, letters and labels, and FDA and EMA drug labels, contain rich safety information on marketed drugs. Post-market AE data can be found in FAERS, and ClinicalTrials.gov includes information on AEs reported in clinical trials. Literature sources provide current and legacy scientific research in abstracts, full-text articles, and preprints. Search across these data sources provides information on the context around any drug, target, or disease.
Benefits of accessing safety vigilance information from the Safety Intelligence Hub include:
Numerous pharmaceutical companies have implemented NLP technology to mine literature to better understand safety signals and improve adverse event detection. Learn more about how the Safety Intelligence Hub can help you enhance drug safety.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
Insights are trapped in mountains of text. NLP sets them free.
Compare and extract critical drug label information.
